Experimental Biology and Medicine
Journal of the Society for
Experimental Biology and Medicine
All manuscripts should be submitted to:
http://ebm.allentrack.net
Please read the following instructions prior to submitting
your manuscript:
Instructions for Authors
Experimental Biology and Medicine is particularly
appropriate for publication of papers that are multidisciplinary in
nature, are of potential interest to a wide audience, and represent
experimental medicine in the broadest sense of the term. However,
manuscripts reporting novel findings on any topic in the realm of
experimental biology and medicine are most welcome. We particularly
encourage submission of manuscripts that describe results of studies
that require an interdisciplinary approach to biomedical issues.
Categories currently listed in EBM are: Anatomy/Pathology; Biochemistry
and
Molecular Biology; Cell and Developmental Biology; Endocrinoogy and
Nutrition;
Immunology/Microbiology/Virology; Neuroscience; Pharmacology and
Toxicology;
Physiology; Bioimaging; Biomedical Engineering; Bionanoscience;
Genomics, Proteomics, and Bioinformatics; Stem Cell Biology; Systems
Biology and Translational Research. Authors should indicate their
preference of category,
although the final decision of reviewing Associate Editor and section
Editorial Board rests with the Editor-in-Chief.
Assistance with English
If English is not your native
language,
you may find it helpful to obtain assistance in writing your papers
before submitting
them to EBM. This may not only save time in the review process but also
increase the
accuracy of your submission. You can find help in scientific writing at
several companies
that include:
www.biosciencewriters.com
www.bostonbioedit.com
www.prof-editing.com
Please note that neither EBM nor SEBM has used these services
and are unable to comment on the quality of their work.
Research Articles
Manuscripts are accepted for review with the understanding
that the same work has not been and, if accepted by EBM, will not be
published elsewhere nor is presently submitted elsewhere; and that its
submission for publication has been approved by all of the authors (as
confirmed by the covering letter). Unnecessary subdivision of a study
into several manuscripts is not acceptable. If any material published
previously is included, for clarity or other reasons, this should be
indicated with appropriate citation in the manuscript.
One copy of any material that might be regarded as "duplicate
publication," such as preliminary reports (including reviews, symposia
and proceedings) or other publications (submitted, in press or
published) containing data or other material included in the submitted
manuscript, must be sent to the Editor when the manuscript is
submitted. Clearly label such material so as to avoid any confusion
with the submitted manuscript. Normally it is regarded as acceptable to
include in a detailed journal article material that has been presented
previously in summary form in reviews, symposia, or conferences,
provided appropriate citation is included.
Brief Communications
Manuscripts describing focused studies that are concise and of
high impact to a field will be published as Brief Communications.
This
format is intended for the presentation of scientifically sound and
novel research in a clear and concise fashion. The body of the paper
should not exceed nine (9) pages of double-spaced text with references.
Tables and Figures must also be kept to a minimum (no more than four).
Formatting should
otherwise follow the requirements for Research Articles.
Minireviews
The journal publishes review articles under the section
heading "Minireviews." Although there is no page limit, the reviews are
generally short (~20 pages of double-spaced text with references). They
should reflect the state-of-the-art of the area being reviewed and
often include a brief history of the field. There is no need to include
an exhaustive literature survey. Emphasis upon a particular hypothesis
or point of view or upon the personal opinions or interpretation of the
writer or upon the work of the writer's laboratory is appropriate,
provided that this focus is clearly indicated in the paper. Most
reviews are submitted in response to an invitation from the
Editor-in-Chief, and are subjected to the usual review
process prior to publication. Unsolicited reviews and reviews solicited
by the Associate Editors need to be approved by the Editor-in-Chief
before
receiving peer review.
Comments
The Journal, at the Editor-in-Chief's discretion, will
publish, under the section heading "Comments," letters or essays from
readers discussing articles that have recently appeared in the Journal
or other timely topics of interest to the Journal's readership. The
author of a letter or essay which is published accepts full
responsibility for the contents of the letter. Letters discussing a
published article may for example include supporting information,
clarifications, criticisms, corrections, alternate interpretations or
perspectives. Such letters will be sent to the corresponding author of
that article prior to publication. If the corresponding or other author
wishes, her/his response will be published together with the original
letter. At the discretion of the editor, essays or letters discussing
controversial issues may be sent to persons representing alternative
viewpoints who will be encouraged to provide responses. If the Editor
decides to publish such responses, they will be sent to the original
author for comments prior to publication. In some cases, the Editor-
in-Chief may send a letter or essay for outside review prior to
deciding whether to publish it. The Society reserves the right to edit
these communications without materially changing their meaning.
Original Research Articles
Style of Manuscripts
1. Manuscripts should be as concise as possible, yet
sufficiently detailed to permit critical appraisal, and should
generally not exceed 40 typed pages (including tables, charts and
references).
2. The Title should be a declarative statement of key
findings and should be limited to 15 words. Use of abbreviations in the
title should generally be avoided. Research articles should be divided
into an Abstract (maximum 300 words), keywords, Introduction, Materials
and Methods, Results, and Discussion sections.
3. Figures. All figures should be cited consecutively
by Arabic numerals in the text with figure legends typed on a separate
sheet. Legends should contain sufficient experimental detail to permit
the figures to be interpreted without reference to the text. Units
should be clearly indicated in the figures themselves. All figures and
illustrations are to be submitted in such form as to permit
photographic reproduction without retouching or redrawing. Line
drawings should be no larger than 8.5 x 11.5 inches overall (21 x 27.5
cm). The lettering should be large enough to allow a reduction of two
thirds.
4. Tables. These should be numbered with Arabic
numerals and cited consecutively in the text. Each table should be
titled and double-spaced on a separate sheet. Refer to current issues
of Experimental Biology and Medicine for the acceptable style
of tables. The title of each table should clearly indicate the nature
of the contents, and sufficient experimental detail should be included
in footnotes to the entries in the table to permit the reader to
interpret the results without reference to the text. Units must be
clearly indicated for each of the entries in the table.
5. Footnotes. Footnotes in the text should be
identified by superscripts consisting of Arabic numerals; footnotes in
the tables should be identified by superscript lowercase letters a, b,
c, etc., and placed at the bottom of the table.
a. Acknowledgments should be typed on a separate page and
placed at the end of the text pages.
6. References.
a. Citations should be used to provide appropriate
attribution and credit to previous investigators. Extensive citation
should be avoided, if possible, while adhering to the applicable
conventions of the scientific community. Authors are responsible for
obtaining permission to reproduce from the appropriate sources cited in
the text.
b. References should be arranged numerically at the end of the
manuscript and cited in the text with Arabic numerals in parentheses,
set on the text line. The references should be numbered consecutively
in order of their citation.
Abbreviations of journal titles should follow the style used
in Index Medicus with a complete list of authors for each reference.
Please follow the style of capitalization and punctuation illustrated
by the following examples:
1. (journal article) Upadhyay D, Kamp DW. Asbestos-induced
pulmonary toxicity:
Role of DNA damage and apoptosis. Exp Biol Med 228:650-659, 2003.
2. (Book) Abramson DI. Circulation in the Extremities. New
York:
Academic Press, p000, 1967.
3. (book chapter) Langford MP, Weigent DA, Stanton GJ, Baron
S. Virus
plaque-reduction assay for interferon: Miroplaque and regular
macroplaque reduction assay. In: Pestka S, Ed. Methods in Enzymology.
New York: Academic Press, Vol Part A 78: p000, 1981.
4. (journal article in press) Hylden JL, Wilcox GL.
Intrathecal morphine in mice: A new
technique. Eur J Pharmacol (in press: volume, year).
c. "Personal communication," "unpublished," and "submitted"
must be excluded from the reference list and cited in a footnote. If a
manuscript being cited has been accepted for publication, include it in
the reference list, giving journal, volume, year as available. In
general, citation of numerous abstracts is discouraged, although
acceptable if necessary to provide proper attribution or credit.
7. Trade name, popular name or abbreviation when first used
must be preceded by the chemical, scientific or technical name;
thereafter, any of these names or abbreviations may be used. Trade
names should begin with a capital letter. Structural formulas of
chemicals should be used only when absolutely necessary. Abbreviations
used should generally be those listed below. Units of weights,
measures, etc., when used in conjunction with numerals, should be
abbreviated and unpunctuated, e.g., 6 R, 3 g, 5 ml, 8%. The metric
system for weights and measurement, degrees Celsius for temperature,
and the 24-hour clock (e.g., 0500h) to express time should be used.
Abbreviations Contributors are requested to use the
following abbreviations: calorie cal
centimeter cm
counts per minute cpm
cubic centimeter cm3
Curie Ci
degree Celsius (centigrade) °C
diameter diam
gram g
inside diameter i.d.
intramuscular im
intraperitoneal ip
intravenous iv
kilocalorie kcal
kilogram kg
liter spell out
meter m
microliter µl
micrometer µm
milligram mg
milliliter ml
millimeter mm
milliosmole mOsm
molal (concentration) m
molar (concentration) M
mole spell out
molecular weight mol wt
nanogram ng
nanometer nm
normal (concentration) N
osmole Osm
outside diameter o.d.
parts per million ppm
percent %
picogram pg
revolutions per minute rpm
second sec
specific activity sp act
square centimeter cm2
square meter m2
subcutaneous sc
volt V
volume vol
Review Process
Two reviewers will generally evaluate each manuscript
on the basis of scientific rigor of the experimental design, adequacy
of the data, validity of the conclusions, importance and originality of
the studies, adequacy of the literature citations, clarity of the
presentation, and interest to the Journal's readership. Manuscripts may
be returned to the authors without detailed review if, in the opinion
of the Editor-in-Chief, they fall outside the scope of interests of the
Journal's readership or if they are not written in clear, concise and
grammatical English.
Manuscripts will be given a quality (priority) ranking by each
reviewer. Those manuscripts with low priority rankings will not be
accepted even though they may have been classed as generally
acceptable. If reviewers differ significantly in their opinions,
decision will be based on the priority rankings and/or the opinion of
an additional reviewer (arbiter). Manuscripts returned after revision
based upon reviewers' comments will be sent back to the original
reviewers together with the authors' responses.
The reviewers' comments will be held in confidence except as
follows: (a) the reviewers' comments may be sent, in whole or in part,
to the corresponding author;(b)after revision, each reviewer's comments
will be sent, in whole or in part, to the other reviewers of the
manuscript: and (c) in the event that there is a significant difference
in opinion between or among the reviewers, the manuscript may be sent
to an additional reviewer (arbiter) together with the comments, in
whole or in part, of the other reviewers. In all cases, anonymity of
the reviewers will be maintained.
Copyright
Authors submitting a manuscript do so on the understanding
that if it is accepted for publication, copyright in the article,
including the right to reproduce the article in all forms and media,
shall be assigned exclusively to the Society. The Society will not
refuse any reasonable request by an author for permission to reproduce
any of their contributions to the Journal. Send requests for permission
to reproduce items published in Experimental Biology and Medicine
to:
Society for Experimental Biology and Medicine
Attn: Permissions Editor
197 West Spring Valley Avenue
Maywood, NJ 07607-1727
USA
Articles and any other materials published in the Experimental
Biology and Medicine represent the opinions of the author(s) and
should not be construed to reflect the opinions of the Editor(s), or
the Society.
Submitted manuscripts and accompanying materials become the
property of the Society, and the Society is not responsible for loss or
damage to such materials. The manuscript must be accompanied by a
covering letter. The letter must state that the
non-signing author(s) have read and approved the manuscript. Any person
cited in the manuscript as a source of "personal communication" or
"unpublished data" must provide signed approval of such citation.
Authors of manuscripts describing original nucleotide or amino
acid sequences must submit the sequence to Gen Bank and obtain
an accession number from Gen Bank before publication of the
manuscript. The accession number should be included in the manuscript
as a footnote or in the appropriate figure legend.
When, as a result of reviewers' comments, it is necessary to
revise a manuscript, it is recommended that, unless additional studies
are required, the authors should resubmit the revised manuscript
promptly; a delay of longer than four months may result in the revised
manuscript receiving a lower priority.
If you have any questions regarding submission, please contact
the Society office:
Tel: 201-291-9080
Fax: 201-291-2988
e-mail: sebm@inch.com
All manuscripts should be submitted to:
http://ebm.allentrack.net
NOTIFY THE EDITORIAL OFFICE AT LEAST
ONE MONTH BEFORE CHANGE OF ADDRESS.
Page and Other Charges
1. Changes in proof should be absolutely minimal. Authors will
be charged for excessive changes.
2. Colored illustrations will only be published if the authors
cover the costs.
3. The authors are required to pay a part of the cost of
publication in the form of a page charge of $50 per page. Manuscripts
for which a member of the SEBM is an author are exempt from page
charges. (Please note the name(s) of the member author(s) when
submitting the manuscript). Authors lacking funding from grant or other
sources may apply at the time of submission for a waiver of page
charges. Apply for a
waiver of page charges in your cover letter at the time of submission.
Applications must be endorsed by a senior institutional official
verifying that no
funds are available for paying page charges. A waiver of page charges
will not be granted once a manuscript has been accepted.
Reprint orders of 1,000 or more should be discussed with
the publisher and authors are generally expected to discourage
circulation of reprints for commercial purposes.
Use of Human and Animal Subjects and Recombinant DNA
Studies involving human subjects must conform to the ethical
standards set by the Belmont Report, Ethical Principles and Guidelines
for the Protection of Human Subjects of Research; must have been
reviewed and approved by the appropriate institutional Review Board
(IRB); and must be presented in such a manner as to assure preservation
of the anonymity of the subjects. It must be stated in the Materials
and Methods section of the article that the study had been approved by
the responsible IRB and that informed consent was obtained from
research subjects or it must be explained why IRB review and /or
informed consent were not required.
It is the Journal's policy that all studies involving the use
of animals be conducted in compliance with applicable laws and
regulations as well as the principles expressed in the National
Institutes of Health, USPHS, Guide for the Care and Use of Laboratory
Animals, and that the studies be conducted on animals that were
lawfully acquired. Use of animals must have been approved by the
Institution's Animal Care and Use Committee (IACUC) and this must be
stated in the Materials and Methods section of the article. If the
study was conducted in a jurisdiction where such review is not
required, this should be noted in the Materials and Methods section.
Experiments involving recombinant DNA must have been reviewed and
approved as required by applicable laws and regulations.
Financial Support and Conflict of Interest
All grant, contract and industrial support of the work
included in the manuscript must be acknowledged in a footnote to the
title of the manuscript. Commercial relationships of any of the authors
that might be viewed as representing a conflict of interest must be
disclosed in a footnote to the applicable author's name. Such
disclosure should be made on a separate page as it will not be sent to
reviewers or influence editorial decisions but will be included in the
published paper.
Corrections
Notice of errors introduced inadvertently into a manuscript
during the publication process will be published under the heading
"Errata."
Corrections authors may wish to make regarding errors that
they introduced into the manuscript or into the data analysis or
interpretation will be published under the section heading "Comments,"
together with any responses by dissenting authors.
Top of Page
|